A study for Efficacy and Safety of Metronomic Administration of Detoxification Chinese Herbs combined with Thalidomide in the Treatment of Elderly or Refractory Relapsed Lymphoma

Shanghai Municiple hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Meet the pathological diagnostic criteria of lymphoma (pathological types are not limited);
•2. Meet the diagnostic criteria for elderly or refractory or relapsed;
•3. Patients assessed as inappropriate or intolerable or unwilling to receive combination chemotherapy and targeted therapy;
•4. ECOG=3;
•5. Survival is expected to be greater than 3 months;
•6. Having signed the informed consent.

•1. Aged<18 years;
•2. Pregnant or lactating women;
•3. History of thrombosis nearly 2 years;
•4. Allergic or allergic to various drugs;
•5. Severe liver and kidney dysfunction;
•6. With severe infection or difficult to control;
•7. Taking other traditional Chinese medicine or taking other clinical trials nearly 2 weeks;
•8. The investigators concluded that patients should not take any other part of the study.

发起方

Shanghai Municiple hospital of Traditional Chinese Medicine